Ozana AI Interpreter

Live medical interpretation in 80+ languages.

Ozana AI Interpreter is a real-time, voice-to-voice medical interpreter. Clinician and patient each speak their own language. Ozana AI interprets both directions in under 200 milliseconds, so the conversation feels natural. No phone lines, no scheduling, no waiting for a human interpreter to join.

What it does

Ozana AI Interpreter turns any device into a bilingual clinical conversation. Speech is captured, translated and spoken back in the other party's language, in real time. It is designed for the pace and vocabulary of medicine: symptoms, medications, procedures, consent and safeguarding.

Key capabilities

80+ languages

Global coverage including major European, Asian, African and Middle Eastern languages.

Under 200 ms latency

Fast enough for a natural back-and-forth conversation at the bedside.

Clinical vocabulary

Trained for medical terminology, dosages, anatomy and procedure names.

No patient app

Runs in the browser. Nothing for the patient to download or sign into.

iOS and Android app

A plug-and-play mobile app for solo clinicians and smaller clinics launches in mid-August, so they can start interpreting immediately.

Works with the Scribe

Pairs with Ozana AI Scribe to produce the clinical note automatically.

Who it is for

Hospitals, GP practices, urgent care, ambulance and emergency services, mental health teams, and any clinical setting where language should not stand between a patient and safe care. From mid-August, solo clinicians and smaller clinics can also use the Ozana AI Interpreter mobile app for iOS and Android for immediate plug-and-play access. See use cases.

Compliance

HIPAA, GDPR and NHS DTAC aligned. End-to-end encrypted. ISO 27001 certification in progress. Read the full compliance posture.

Differentiators

Purpose-built for clinical use, not a general-purpose translator. Multilingual from day one. Zero-storage by architecture, not by policy. Designed to pair with a multilingual AI scribe on the same engine.